Bert J. C. Janssen 2026-11-05
Bert J. C. Janssen is the first author of a 2005 structural study of Complement C3 and its processed fragment C3c. The team determined crystal structures that connected the arrangement of protein domains to activation and regulation in the complement system.[ref]
The structures helped explain how a reactive thioester, needed for later covalent attachment, can remain protected against premature hydrolysis. Comparing the native and processed forms also revealed substantial changes in domain arrangement.[ref]
The comparison is specifically Complement C3 versus C3c. It is not a direct pair of structures showing native Complement C3 and active C3b. Keeping the fragments distinct matters because different stages of processing have different biological roles: an informative structural difference is not automatically the exact movement that creates an active intermediate.
C3a 2026-11-05
C3a is a small protein fragment released when Complement C3 is cleaved during activation of the complement system. It is an anaphylatoxin, associated with inflammatory responses, and is distinct from the larger C3b product involved in surface-associated complement reactions. Proteolysis can thus produce different activities from different parts of one precursor.[ref]
Structures of complement component C3 provide insights into the function and evolution of immunity by Bert J. C. Janssen and others. Introduction and Figure1: C3 activation and fragment organization
In 1969, Viktor A. Bokisch and collaborators isolated C3a by several methods and tested its smooth muscle-contracting activity. Antiserum directed against C3a inhibited the biological response, connecting the isolated fragment to the activity rather than identifying it solely by a separation band. Further enzyme treatment changed its measured activities, showing why the amount of a fragment and its retained function are separate questions.[ref]
Isolation of a fragment (C3a) of the third component of human complement containing anaphylatoxin and chemotactic activity and description of an anaphylatoxin inactivator of human serum by Viktor A. Bokisch and others. Abstract: isolation, smooth-muscle response, antiserum inhibition and enzyme treatment
An idealized bookkeeping example starts with 50 molecules of Complement C3, each undergoing exactly one activation cleavage. It produces 50 C3a fragments and 50 C3b fragments: 100 product molecules, but no doubling of total protein material. In an actual sample, production, further processing and removal all affect the measured concentration of C3a.
C3c 2026-11-05
C3c is a major proteolysis product of Complement C3. It is a processed fragment, distinct from the small inflammatory fragment C3a and the activated C3b from which later breakdown products can be generated. A fragment name identifies a particular piece of the original protein, rather than a separate gene product.
The 1969 fragment-isolation study separated C3c and a smaller fragment from enzyme-treated C3b and distinguished them antigenically. This is a biochemical way to establish that further processing yields different molecular pieces.[ref]
In 2005, X-ray crystallography provided crystal structures of native Complement C3 and C3c. Comparing their protein domain arrangements connected cleavage with changes in molecular architecture. The deposited structures are 2A73 for native Complement C3 and 2A74 for C3c.[ref]
Structures of complement component C3 provide insights into the function and evolution of immunity by Bert J. C. Janssen and others. Abstract; Figures1–2; coordinate-deposition statement
Consider an original interpretation exercise: an antibody signal from a region retained in C3c could persist after the intact precursor has disappeared. Such a signal would not by itself measure intact Complement C3, newly generated C3a or surface-attached C3b. Knowing the recognized region and the sample's processing state is essential when choosing what an assay measures.
Complement C3 2026-11-05
Complement C3 is a central protein of the complement system. Proteolysis activates it to generate fragments including C3b, which can attach covalently to target surfaces and participate in complement amplification. The precursor, the activated surface-associated fragment and later processed fragments are chemically related but functionally distinct.[ref]
Structure of complement fragment C3b-factor H and implications for host protection by complement regulators by Jin Wu and others. Introduction: C3 activation, C3b attachment and regulation
A 2005 structural study compared native Complement C3 with its major processed fragment C3c. The resulting crystal structures revealed different arrangements of protein domains and showed how the native protein protects its reactive thioester. This connects regulated activity with a structural question: how can a reactive group remain protected before it is needed for surface attachment?[ref]
Structures of complement component C3 provide insights into the function and evolution of immunity by Bert J. C. Janssen and others. Abstract; Figures1–2 and4: C3/C3c comparison and thioester protection